Innovating intelligent cleanroom control systems
By Catherine Eckford (European Pharmaceutical Review)
Drug for rare form of Alzheimer’s “scientifically promising”
By Catherine Eckford (European Pharmaceutical Review)
Psilocybin therapy demonstrates sustained clinical benefit in treatment-resistant depression
By Catherine Eckford (European Pharmaceutical Review)
Novo Nordisk industry membership reinstated
By Catherine Eckford (European Pharmaceutical Review)
Preparing for a new era in the rare disease sector
By Catherine Eckford (European Pharmaceutical Review), Christina Gkousgkouni (Sanofi)
Harnessing industry advancements to accelerate upstream process development
By Dr Li Yang (Altruist Biologics), Dr Shidong Shi (Altruist…